Rockfield Medical Devices

Executive Summary

Rockfield Medical Devices is an Irish medical device company dedicated to improving the quality of life for tube-fed patients through innovative enteral feeding solutions. Founded in 2004 and headquartered in Galway, the company addresses a critical need in the home healthcare market with its flagship product, the Mobility+® system. Unlike traditional electronic pumps that tether patients to power sources and limit movement, Mobility+® is a mechanical, non-electronic pump that leverages the patient's own body movements to deliver nutrition. This unique design enhances patient mobility, reduces dependence on caregivers, and eliminates the risks associated with electronic failures. The device has received CE Mark approval in Europe, validating its safety and efficacy and paving the way for commercialization. With an aging global population and rising prevalence of chronic conditions requiring enteral feeding, the market for innovative feeding systems is expanding. Rockfield's differentiation lies in its simple, low-cost, and patient-centric approach, which has the potential to disrupt the stagnant enteral feeding device market dominated by electronic pumps. The company is now poised for commercial expansion, targeting both home care and institutional settings. While specific financials and commercialization timelines are undisclosed, the CE Mark provides a strong foundation for revenue generation in European markets. Success will depend on execution, market adoption, and regulatory approvals in other key regions such as the United States.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) submission for Mobility+® system60% success
• Q3 2026First commercial sales in Europe following CE Mark70% success
• Q1 2027Strategic partnership or distribution agreement with a major medical device company40% success